This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, H. Articles by Iadecola, C. Search for Related Content PubMed PubMed Citation Articles by Li, H. Articles by Iadecola, C. Pubmed/NCBI databases Substance via MeSH Related Collections Animal models of human disease Apoptosis Ischemic biology - basic studies Acute Cerebral Infarction Neuroprotectors

(Stroke. 2000;31:176.)
© 2000 American Heart Association, Inc.

Original Contributions

Caspase Inhibitors Reduce Neuronal Injury After Focal but Not Global Cerebral Ischemia in Rats

Hui Li, MD; Frederick Colbourne, PhD; Ping Sun, MD; Zonghang Zhao, MD Alastair M. Buchan, MD, FRCP

From the Alberta Stroke Program, Departments of Clinical Neurosciences (H.L., P.S., Z.Z., A.M.B.) and Pathology (F.C.), Neuroscience Research Group, University of Calgary, Alberta, Canada.

Correspondence to Alastair M. Buchan, Professor of Stroke Research, Alberta Stroke Program, Department of Clinical Neurosciences, Foothills Hospital, Room 1162, 1403 29th St NW, Calgary, Alberta, Canada T2N 2T9. E-mail buchan{at}ucalgary.ca

Background and Purpose—Studies show that blocking the activation of caspases by the caspase inhibitors z-VAD.FMK and z-DEVD.FMK can reduce ischemic neuronal injury after cerebral ischemia. Because the severity of ischemia was mild in some studies, we tested the efficacy of these caspase inhibitors on moderately severe but transient forebrain and focal ischemic insults in the rat.

Methods—Various regimens of z-VAD, z-DEVD, and control DMSO were given to rats subjected to either 4-vessel occlusion ischemia (4-VO, 10-minute occlusion, 7-day survival) or distal middle cerebral artery occlusion (MCAo, 90-minute occlusion, 22.5-hour survival). In global ischemia, treatments were given immediately after ischemia (experiment 1) or as preischemic and postischemic treatments (experiment 2). Three focal ischemia experiments were done. Injection times were 60 minutes into ischemia (experiment 1) and 60 minutes into ischemia plus 30 and 120 minutes after ischemia (experiment 2). Experiment 3 was identical to experiment 2 except that a 30-minute preischemia treatment was instituted. Core normothermia was maintained in all experiments during ischemia. However, in the last focal and global experiments, core and brain temperatures, respectively, were also measured after ischemia with telemetry probes. Because hyperthermia accompanied z-DEVD treatment, an extra z-DEVD–treated group (MCAo) was included with temperature clamped at normothermia.

Results—Neither z-VAD nor z-DEVD significantly reduced CA1 injury after global ischemia. In focal ischemia, both drugs significantly reduced infarction, but only in the third experiment, and the prevention of hyperthermia that accompanied z-DEVD treatment did not alter this.

Conclusions—These results suggest a detrimental role of caspases in moderately severe focal but not global cerebral ischemia.

Editorial Comment

Costantino Iadecola, MD, Guest Editor

Center for Clinical and Molecular Neurobiology, Departments of Neurology and Neuroscience, University of Minnesota, Minneapolis, Minnesota

This article has been cited by other articles:

				F. Liu, Z. Li, J. Li, C. Siegel, R. Yuan, and L. D. McCullough Sex Differences in Caspase Activation After Stroke Stroke, May 1, 2009; 40(5): 1842 - 1848. [Abstract] [Full Text] [PDF]

				A. Schneider, B. W. Bottiger, and E. Popp Cerebral Resuscitation After Cardiocirculatory Arrest Anesth. Analg., March 1, 2009; 108(3): 971 - 979. [Abstract] [Full Text] [PDF]

				W. J Mach, A. R Knight, J. A Orr, and J. D Pierce Apoptosis and haemorrhagic shock Journal of Research in Nursing, January 1, 2009; 14(1): 77 - 88. [Abstract] [PDF]

				C. L. Edelstein, T. S. Hoke, H. Somerset, W. Fang, C. L. Klein, C. A. Dinarello, and S. Faubel Proximal tubules from caspase-1-deficient mice are protected against hypoxia-induced membrane injury Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1052 - 1061. [Abstract] [Full Text] [PDF]

				S. Inoue, D. P. Davis, J. C. Drummond, D. J. Cole, and P. M. Patel The combination of isoflurane and caspase 8 inhibition results in sustained neuroprotection in rats subject to focal cerebral ischemia. Anesth. Analg., May 1, 2006; 102(5): 1548 - 1555. [Abstract] [Full Text] [PDF]

				U. Fischer and K. Schulze-Osthoff New Approaches and Therapeutics Targeting Apoptosis in Disease Pharmacol. Rev., June 1, 2005; 57(2): 187 - 215. [Abstract] [Full Text] [PDF]

				P. A. Barber, L. Hoyte, F. Colbourne, and A. M. Buchan Temperature-Regulated Model of Focal Ischemia in the Mouse: A Study With Histopathological and Behavioral Outcomes Stroke, July 1, 2004; 35(7): 1720 - 1725. [Abstract] [Full Text] [PDF]

				X.-M. Yin, Y. Luo, G. Cao, L. Bai, W. Pei, D. K. Kuharsky, and J. Chen Bid-mediated Mitochondrial Pathway Is Critical to Ischemic Neuronal Apoptosis and Focal Cerebral Ischemia J. Biol. Chem., October 25, 2002; 277(44): 42074 - 42081. [Abstract] [Full Text] [PDF]

				B. H. Han, D. Xu, J. Choi, Y. Han, S. Xanthoudakis, S. Roy, J. Tam, J. Vaillancourt, J. Colucci, R. Siman, et al. Selective, Reversible Caspase-3 Inhibitor Is Neuroprotective and Reveals Distinct Pathways of Cell Death after Neonatal Hypoxic-ischemic Brain Injury J. Biol. Chem., August 9, 2002; 277(33): 30128 - 30136. [Abstract] [Full Text] [PDF]

				H. Yanamoto, I. Nagata, Y. Niitsu, Z. Zhang, J.-H. Xue, N. Sakai, H. Kikuchi, and C. Iadecola Prolonged Mild Hypothermia Therapy Protects the Brain Against Permanent Focal Ischemia Editorial Comment Stroke, January 1, 2001; 32(1): 232 - 239. [Abstract] [Full Text] [PDF]